Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoglycemic Agents | 12 | 2015 | 3086 | 0.560 |
Why?
|
Diabetes Mellitus, Type 2 | 27 | 2015 | 12145 | 0.510 |
Why?
|
Diabetes Mellitus | 18 | 2013 | 5841 | 0.480 |
Why?
|
Dysthymic Disorder | 1 | 2013 | 75 | 0.440 |
Why?
|
Islets of Langerhans Transplantation | 4 | 2015 | 743 | 0.420 |
Why?
|
Insulin | 19 | 2015 | 6588 | 0.380 |
Why?
|
Diabetes Mellitus, Type 1 | 10 | 2015 | 3416 | 0.370 |
Why?
|
Inpatients | 5 | 2013 | 2545 | 0.320 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2010 | 197 | 0.320 |
Why?
|
Blood Glucose | 21 | 2015 | 6390 | 0.310 |
Why?
|
Fibronectins | 9 | 1997 | 724 | 0.290 |
Why?
|
Islets of Langerhans | 3 | 2008 | 1341 | 0.280 |
Why?
|
Endothelium, Vascular | 12 | 1997 | 4421 | 0.280 |
Why?
|
Diabetes Complications | 3 | 2003 | 1315 | 0.270 |
Why?
|
Glucose | 12 | 2006 | 4341 | 0.240 |
Why?
|
C-Peptide | 5 | 2015 | 441 | 0.220 |
Why?
|
Cushing Syndrome | 2 | 2000 | 241 | 0.210 |
Why?
|
Graft Survival | 2 | 2015 | 3841 | 0.200 |
Why?
|
Hyperglycemia | 6 | 2013 | 1375 | 0.190 |
Why?
|
Self Care | 4 | 2013 | 795 | 0.190 |
Why?
|
Megestrol | 1 | 2000 | 9 | 0.180 |
Why?
|
Shoulder | 1 | 2002 | 301 | 0.170 |
Why?
|
Peripheral Arterial Disease | 1 | 2011 | 1274 | 0.170 |
Why?
|
Diabetic Angiopathies | 7 | 2009 | 805 | 0.150 |
Why?
|
Depressive Disorder, Major | 2 | 2013 | 4766 | 0.150 |
Why?
|
Ethics, Nursing | 1 | 2017 | 24 | 0.140 |
Why?
|
Adrenal Glands | 1 | 2000 | 552 | 0.140 |
Why?
|
Extracellular Matrix | 3 | 1997 | 1720 | 0.140 |
Why?
|
Musculoskeletal Diseases | 2 | 2002 | 597 | 0.140 |
Why?
|
Hand | 1 | 2002 | 902 | 0.140 |
Why?
|
RNA, Messenger | 14 | 1996 | 12743 | 0.140 |
Why?
|
Rheumatic Diseases | 1 | 2003 | 649 | 0.130 |
Why?
|
Patient Advocacy | 2 | 2017 | 359 | 0.130 |
Why?
|
Pregnancy in Diabetics | 2 | 1996 | 197 | 0.130 |
Why?
|
Graft Rejection | 1 | 2008 | 4479 | 0.120 |
Why?
|
Diabetic Retinopathy | 5 | 2007 | 1274 | 0.120 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 1996 | 1116 | 0.120 |
Why?
|
Hypoglycemia | 2 | 2015 | 883 | 0.120 |
Why?
|
Ergocalciferols | 1 | 2015 | 110 | 0.120 |
Why?
|
Basement Membrane | 3 | 1991 | 348 | 0.120 |
Why?
|
Retinal Vessels | 4 | 2007 | 854 | 0.110 |
Why?
|
Methyl Methanesulfonate | 1 | 1993 | 28 | 0.110 |
Why?
|
Outpatient Clinics, Hospital | 3 | 2004 | 392 | 0.110 |
Why?
|
Cell Division | 6 | 1997 | 4451 | 0.110 |
Why?
|
Streptozocin | 1 | 1993 | 193 | 0.100 |
Why?
|
Research Subjects | 1 | 2014 | 249 | 0.100 |
Why?
|
Research Personnel | 1 | 2017 | 588 | 0.100 |
Why?
|
Heart Diseases | 1 | 2005 | 2795 | 0.100 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 1993 | 286 | 0.100 |
Why?
|
Laminin | 1 | 1993 | 407 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2000 | 1520 | 0.090 |
Why?
|
Middle Aged | 38 | 2015 | 220835 | 0.090 |
Why?
|
Antipsychotic Agents | 4 | 2007 | 3063 | 0.090 |
Why?
|
Capillaries | 2 | 1991 | 755 | 0.090 |
Why?
|
Blotting, Northern | 4 | 1993 | 1544 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2000 | 1365 | 0.090 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1991 | 818 | 0.090 |
Why?
|
Insulin Resistance | 4 | 2015 | 3951 | 0.090 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2013 | 468 | 0.090 |
Why?
|
Advisory Committees | 1 | 2014 | 788 | 0.080 |
Why?
|
Delivery of Health Care | 1 | 2007 | 5333 | 0.080 |
Why?
|
Aged | 31 | 2014 | 169266 | 0.080 |
Why?
|
Glucagon | 5 | 1986 | 531 | 0.080 |
Why?
|
Congenital Abnormalities | 2 | 1996 | 707 | 0.080 |
Why?
|
Humans | 78 | 2017 | 761098 | 0.080 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 2008 | 113 | 0.080 |
Why?
|
Female | 52 | 2015 | 392458 | 0.080 |
Why?
|
Risk Reduction Behavior | 2 | 2013 | 1111 | 0.080 |
Why?
|
Thiazolidinediones | 2 | 2009 | 460 | 0.080 |
Why?
|
Portal Vein | 2 | 2008 | 432 | 0.080 |
Why?
|
Collagen | 3 | 1991 | 2635 | 0.070 |
Why?
|
Schizophrenia | 5 | 2007 | 6929 | 0.070 |
Why?
|
Program Development | 1 | 2014 | 1292 | 0.070 |
Why?
|
Transforming Growth Factor beta | 1 | 1995 | 1964 | 0.070 |
Why?
|
Male | 50 | 2015 | 360675 | 0.070 |
Why?
|
Paraneoplastic Endocrine Syndromes | 1 | 1987 | 29 | 0.070 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2007 | 92 | 0.070 |
Why?
|
Gene Expression Regulation | 5 | 1993 | 11856 | 0.070 |
Why?
|
ACTH Syndrome, Ectopic | 1 | 1987 | 30 | 0.070 |
Why?
|
Cyclic AMP | 1 | 1991 | 1463 | 0.070 |
Why?
|
Adult | 37 | 2015 | 221083 | 0.070 |
Why?
|
Family Practice | 2 | 2007 | 507 | 0.070 |
Why?
|
Injections, Subcutaneous | 1 | 2008 | 672 | 0.070 |
Why?
|
Fatal Outcome | 2 | 2008 | 1837 | 0.070 |
Why?
|
Potassium | 4 | 1986 | 1309 | 0.070 |
Why?
|
Umbilical Veins | 6 | 1997 | 423 | 0.070 |
Why?
|
Boston | 4 | 2017 | 9324 | 0.070 |
Why?
|
Coronary Restenosis | 1 | 2009 | 396 | 0.070 |
Why?
|
Dibenzothiazepines | 1 | 2006 | 102 | 0.060 |
Why?
|
Counseling | 1 | 2013 | 1536 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1388 | 0.060 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 1987 | 361 | 0.060 |
Why?
|
Medication Adherence | 2 | 2013 | 2175 | 0.060 |
Why?
|
RNA | 2 | 1993 | 2708 | 0.060 |
Why?
|
Specialization | 2 | 2007 | 778 | 0.060 |
Why?
|
Autopsy | 1 | 2008 | 1010 | 0.060 |
Why?
|
Vasodilator Agents | 1 | 2009 | 989 | 0.060 |
Why?
|
Health Status Indicators | 2 | 2008 | 970 | 0.060 |
Why?
|
Hypercholesterolemia | 2 | 2002 | 1141 | 0.060 |
Why?
|
Cells, Cultured | 13 | 1997 | 18926 | 0.060 |
Why?
|
Diabetic Ketoacidosis | 1 | 2007 | 253 | 0.060 |
Why?
|
Adenocarcinoma | 2 | 2000 | 6340 | 0.050 |
Why?
|
Interleukin-1 | 3 | 1993 | 1250 | 0.050 |
Why?
|
Atrophy | 1 | 2008 | 1633 | 0.050 |
Why?
|
DNA Damage | 1 | 1993 | 2443 | 0.050 |
Why?
|
Disease Management | 2 | 2004 | 2508 | 0.050 |
Why?
|
Patient Education as Topic | 2 | 2005 | 2316 | 0.050 |
Why?
|
Mass Screening | 2 | 2008 | 5425 | 0.050 |
Why?
|
von Willebrand Factor | 4 | 1994 | 677 | 0.050 |
Why?
|
Cerebral Infarction | 1 | 2007 | 981 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2015 | 3410 | 0.050 |
Why?
|
Plasminogen Inactivators | 2 | 1992 | 37 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2014 | 3568 | 0.050 |
Why?
|
Treatment Failure | 1 | 2008 | 2643 | 0.050 |
Why?
|
Reference Values | 2 | 2008 | 4922 | 0.050 |
Why?
|
Tenosynovitis | 1 | 2002 | 57 | 0.050 |
Why?
|
Evidence-Based Medicine | 4 | 2014 | 3689 | 0.050 |
Why?
|
Internet | 2 | 2005 | 3094 | 0.050 |
Why?
|
Superoxide Dismutase | 2 | 1996 | 593 | 0.050 |
Why?
|
Bursitis | 1 | 2002 | 80 | 0.050 |
Why?
|
Medicine | 2 | 2007 | 942 | 0.050 |
Why?
|
Dupuytren Contracture | 1 | 2002 | 66 | 0.050 |
Why?
|
Hemodynamics | 2 | 2007 | 4164 | 0.050 |
Why?
|
Patient Compliance | 2 | 2008 | 2687 | 0.050 |
Why?
|
Hemoglobins | 1 | 2007 | 1525 | 0.050 |
Why?
|
Clozapine | 2 | 2005 | 504 | 0.050 |
Why?
|
Hypertonic Solutions | 3 | 1995 | 82 | 0.050 |
Why?
|
Hypolipidemic Agents | 1 | 2005 | 609 | 0.040 |
Why?
|
Primary Health Care | 4 | 2007 | 4673 | 0.040 |
Why?
|
Retina | 3 | 2007 | 2656 | 0.040 |
Why?
|
Glucose Tolerance Test | 4 | 2008 | 1178 | 0.040 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1213 | 0.040 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2000 | 118 | 0.040 |
Why?
|
Attitude to Health | 1 | 2008 | 2024 | 0.040 |
Why?
|
Proteins | 2 | 1993 | 5993 | 0.040 |
Why?
|
Risk Factors | 11 | 2015 | 74219 | 0.040 |
Why?
|
Evoked Potentials, Visual | 1 | 2001 | 417 | 0.040 |
Why?
|
Depressive Disorder | 2 | 2008 | 3727 | 0.040 |
Why?
|
Quality Improvement | 1 | 2014 | 3801 | 0.040 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2002 | 303 | 0.040 |
Why?
|
Actins | 4 | 1997 | 2046 | 0.040 |
Why?
|
Societies, Medical | 2 | 2007 | 3923 | 0.040 |
Why?
|
Drug Costs | 1 | 2006 | 1183 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4786 | 0.040 |
Why?
|
Kinetics | 4 | 1993 | 6312 | 0.040 |
Why?
|
Body Weight | 3 | 2006 | 4618 | 0.040 |
Why?
|
Visual Pathways | 1 | 2001 | 551 | 0.040 |
Why?
|
Hypertension | 4 | 2006 | 8537 | 0.030 |
Why?
|
Acute Disease | 1 | 2007 | 7240 | 0.030 |
Why?
|
Emergency Service, Hospital | 2 | 2008 | 7873 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2000 | 566 | 0.030 |
Why?
|
Prevalence | 3 | 2008 | 15717 | 0.030 |
Why?
|
Odds Ratio | 2 | 2006 | 9648 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 2 | 1992 | 1162 | 0.030 |
Why?
|
Young Adult | 5 | 2015 | 59199 | 0.030 |
Why?
|
Feedback | 1 | 1999 | 790 | 0.030 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2015 | 40 | 0.030 |
Why?
|
Free Radical Scavengers | 1 | 1996 | 211 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2005 | 2019 | 0.030 |
Why?
|
Adolescent | 8 | 2014 | 88271 | 0.030 |
Why?
|
Prednisone | 1 | 2000 | 1565 | 0.030 |
Why?
|
Gene Expression | 4 | 2000 | 7567 | 0.030 |
Why?
|
Stress, Psychological | 2 | 2008 | 4488 | 0.030 |
Why?
|
Blood Platelets | 2 | 1983 | 2477 | 0.030 |
Why?
|
Calcifediol | 1 | 2015 | 160 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2005 | 2638 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 1995 | 522 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 3 | 1996 | 8164 | 0.030 |
Why?
|
Vision Disorders | 1 | 2001 | 1088 | 0.030 |
Why?
|
Linear Models | 2 | 2005 | 5869 | 0.030 |
Why?
|
Rats, Mutant Strains | 1 | 1993 | 60 | 0.030 |
Why?
|
Transcription Factors | 1 | 1993 | 12096 | 0.030 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1993 | 77 | 0.030 |
Why?
|
Transcription Factor CHOP | 1 | 1993 | 68 | 0.030 |
Why?
|
Poly A | 1 | 1993 | 180 | 0.030 |
Why?
|
Recombinant Proteins | 3 | 1993 | 6507 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2010 | 58946 | 0.030 |
Why?
|
Coronary Disease | 2 | 2005 | 5921 | 0.030 |
Why?
|
Physician's Role | 1 | 1999 | 916 | 0.030 |
Why?
|
Cross-Sectional Studies | 4 | 2008 | 26068 | 0.030 |
Why?
|
Insulinoma | 1 | 1993 | 121 | 0.030 |
Why?
|
Patient Care Team | 1 | 2004 | 2513 | 0.030 |
Why?
|
Cohort Studies | 7 | 2015 | 41486 | 0.030 |
Why?
|
DNA Probes | 1 | 1993 | 541 | 0.020 |
Why?
|
Blood Pressure | 2 | 2005 | 8478 | 0.020 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1991 | 100 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 1997 | 1334 | 0.020 |
Why?
|
Transcription, Genetic | 5 | 1992 | 7574 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2015 | 39121 | 0.020 |
Why?
|
Rats | 5 | 1996 | 23713 | 0.020 |
Why?
|
Hyperkalemia | 3 | 1983 | 233 | 0.020 |
Why?
|
RNA Probes | 1 | 1991 | 111 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2000 | 3512 | 0.020 |
Why?
|
Patient Selection | 1 | 2003 | 4245 | 0.020 |
Why?
|
Sialoglycoproteins | 1 | 1992 | 315 | 0.020 |
Why?
|
Microbial Collagenase | 1 | 1991 | 112 | 0.020 |
Why?
|
Fibrinolysis | 1 | 1992 | 332 | 0.020 |
Why?
|
United States | 6 | 2008 | 72337 | 0.020 |
Why?
|
Depression | 2 | 2007 | 8130 | 0.020 |
Why?
|
Hyperlipidemias | 2 | 2006 | 771 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1991 | 1301 | 0.020 |
Why?
|
Cricetinae | 1 | 1993 | 2412 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2017 | 2696 | 0.020 |
Why?
|
Benzodiazepines | 2 | 2006 | 1134 | 0.020 |
Why?
|
Up-Regulation | 2 | 1995 | 4111 | 0.020 |
Why?
|
Blood Vessels | 2 | 1985 | 1111 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 1731 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 825 | 0.020 |
Why?
|
Molecular Weight | 1 | 1991 | 2171 | 0.020 |
Why?
|
Hemostasis | 1 | 1991 | 470 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2015 | 12341 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2000 | 2527 | 0.020 |
Why?
|
Metyrapone | 1 | 1987 | 22 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 1993 | 1668 | 0.020 |
Why?
|
Body Mass Index | 4 | 2008 | 12951 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2007 | 239 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2002 | 22157 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2003 | 8000 | 0.020 |
Why?
|
Thromboplastin | 1 | 1989 | 286 | 0.020 |
Why?
|
Arginine | 2 | 1981 | 921 | 0.020 |
Why?
|
Registries | 3 | 2012 | 8236 | 0.020 |
Why?
|
Somatostatin | 3 | 1986 | 447 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1505 | 0.020 |
Why?
|
Health Surveys | 2 | 2007 | 4036 | 0.020 |
Why?
|
Protein Kinase C | 1 | 1991 | 1202 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2000 | 10755 | 0.020 |
Why?
|
Thrombin | 1 | 1989 | 593 | 0.020 |
Why?
|
Qualitative Research | 1 | 2017 | 3016 | 0.020 |
Why?
|
Risk | 3 | 2015 | 9614 | 0.020 |
Why?
|
Prognosis | 3 | 2015 | 29672 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1993 | 6123 | 0.020 |
Why?
|
Platelet Adhesiveness | 2 | 1983 | 154 | 0.020 |
Why?
|
Retreatment | 1 | 2006 | 598 | 0.020 |
Why?
|
Sickness Impact Profile | 1 | 2006 | 299 | 0.020 |
Why?
|
Physicians, Family | 1 | 2007 | 348 | 0.020 |
Why?
|
Demyelinating Diseases | 1 | 2007 | 352 | 0.010 |
Why?
|
Health Behavior | 2 | 2007 | 2641 | 0.010 |
Why?
|
Quality of Life | 1 | 2006 | 13362 | 0.010 |
Why?
|
Nursing Assessment | 1 | 2004 | 106 | 0.010 |
Why?
|
Protein Kinases | 1 | 1991 | 1607 | 0.010 |
Why?
|
Gestational Age | 1 | 1993 | 3577 | 0.010 |
Why?
|
Muscle Weakness | 1 | 2007 | 412 | 0.010 |
Why?
|
Hospitalization | 1 | 2004 | 10712 | 0.010 |
Why?
|
Opportunistic Infections | 1 | 2006 | 376 | 0.010 |
Why?
|
Phenylacetates | 1 | 1983 | 111 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2014 | 2218 | 0.010 |
Why?
|
Vasculitis | 1 | 2007 | 522 | 0.010 |
Why?
|
Age Factors | 3 | 2006 | 18385 | 0.010 |
Why?
|
Nutrition Assessment | 1 | 2006 | 726 | 0.010 |
Why?
|
Coronary Stenosis | 1 | 2009 | 802 | 0.010 |
Why?
|
Isoantibodies | 1 | 2006 | 674 | 0.010 |
Why?
|
Pancreatic Neoplasms | 2 | 1993 | 5366 | 0.010 |
Why?
|
Clonidine | 1 | 1983 | 168 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2012 | 64670 | 0.010 |
Why?
|
Age Distribution | 1 | 2008 | 2873 | 0.010 |
Why?
|
Guanidines | 1 | 1983 | 194 | 0.010 |
Why?
|
Risperidone | 1 | 2005 | 381 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2009 | 15308 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2008 | 2359 | 0.010 |
Why?
|
Deamino Arginine Vasopressin | 1 | 1982 | 87 | 0.010 |
Why?
|
Arginine Vasopressin | 1 | 1982 | 125 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2009 | 1724 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2007 | 12975 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2006 | 2217 | 0.010 |
Why?
|
Employment | 1 | 2008 | 1114 | 0.010 |
Why?
|
Comorbidity | 2 | 2006 | 10514 | 0.010 |
Why?
|
Quality of Health Care | 2 | 2006 | 4319 | 0.010 |
Why?
|
Goals | 1 | 2006 | 708 | 0.010 |
Why?
|
Medical Records | 1 | 2007 | 1409 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2006 | 746 | 0.010 |
Why?
|
Growth Hormone | 1 | 1983 | 569 | 0.010 |
Why?
|
Choice Behavior | 1 | 2007 | 824 | 0.010 |
Why?
|
Nutrition Surveys | 1 | 2008 | 1722 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 1984 | 643 | 0.010 |
Why?
|
Curriculum | 1 | 2014 | 3739 | 0.010 |
Why?
|
Naloxone | 1 | 1983 | 370 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2006 | 15513 | 0.010 |
Why?
|
Brain | 1 | 2007 | 27097 | 0.010 |
Why?
|
Fatigue | 1 | 2007 | 1550 | 0.010 |
Why?
|
Attitude of Health Personnel | 2 | 2004 | 3882 | 0.010 |
Why?
|
Rats, Inbred Strains | 2 | 1992 | 2087 | 0.010 |
Why?
|
Contrast Sensitivity | 1 | 2001 | 253 | 0.010 |
Why?
|
Transplantation Conditioning | 1 | 2006 | 1591 | 0.010 |
Why?
|
Dexamethasone | 1 | 1987 | 1945 | 0.010 |
Why?
|
Animals | 6 | 1996 | 168083 | 0.010 |
Why?
|
Blood Coagulation Factors | 1 | 1982 | 366 | 0.010 |
Why?
|
Patient Discharge | 1 | 2012 | 3441 | 0.010 |
Why?
|
Headache | 1 | 2007 | 1255 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2478 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14607 | 0.010 |
Why?
|
Medical Staff, Hospital | 1 | 2003 | 601 | 0.010 |
Why?
|
Administration, Oral | 1 | 2007 | 4014 | 0.010 |
Why?
|
DNA Replication | 1 | 1985 | 1415 | 0.010 |
Why?
|
Cell Survival | 2 | 1985 | 5776 | 0.010 |
Why?
|
Cytochalasin D | 1 | 1997 | 91 | 0.010 |
Why?
|
Vinculin | 1 | 1997 | 59 | 0.010 |
Why?
|
Health Resources | 1 | 2004 | 934 | 0.010 |
Why?
|
Valproic Acid | 1 | 2000 | 443 | 0.010 |
Why?
|
Educational Status | 1 | 2005 | 2510 | 0.010 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 1997 | 109 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15845 | 0.010 |
Why?
|
Area Under Curve | 1 | 2001 | 1636 | 0.010 |
Why?
|
Pregnancy | 3 | 1996 | 29872 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2003 | 934 | 0.010 |
Why?
|
Hypertriglyceridemia | 1 | 2000 | 293 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2009 | 4506 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1993 | 8529 | 0.010 |
Why?
|
Cell Cycle | 1 | 1985 | 2926 | 0.010 |
Why?
|
Stents | 1 | 2009 | 3177 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1997 | 426 | 0.010 |
Why?
|
Culture Media | 2 | 1992 | 894 | 0.010 |
Why?
|
Phosphates | 1 | 1980 | 763 | 0.010 |
Why?
|
Obesity | 3 | 2005 | 12937 | 0.010 |
Why?
|
Health Services Research | 1 | 2004 | 1807 | 0.010 |
Why?
|
Social Class | 1 | 2005 | 1993 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2007 | 2632 | 0.010 |
Why?
|
Catalase | 1 | 1996 | 217 | 0.010 |
Why?
|
Incidence | 2 | 2007 | 21357 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2006 | 5249 | 0.010 |
Why?
|
Amiloride | 1 | 1995 | 116 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1996 | 224 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2006 | 2769 | 0.010 |
Why?
|
Glutathione Peroxidase | 1 | 1996 | 258 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12058 | 0.010 |
Why?
|
Culture Techniques | 1 | 1995 | 531 | 0.010 |
Why?
|
Migraine Disorders | 1 | 2007 | 1701 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2008 | 7804 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2006 | 4189 | 0.010 |
Why?
|
Skin | 1 | 2007 | 4473 | 0.010 |
Why?
|
Health Care Costs | 1 | 2006 | 3238 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2004 | 2757 | 0.010 |
Why?
|
Trypsin | 1 | 1994 | 486 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4565 | 0.010 |
Why?
|
Health Status | 1 | 2006 | 4077 | 0.010 |
Why?
|
Time Factors | 2 | 1993 | 39953 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2007 | 80673 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1996 | 1703 | 0.010 |
Why?
|
Methylurea Compounds | 1 | 1992 | 3 | 0.010 |
Why?
|
Phenanthrolines | 1 | 1992 | 49 | 0.010 |
Why?
|
Triglycerides | 1 | 2000 | 2457 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2007 | 4947 | 0.010 |
Why?
|
Diuretics | 1 | 1995 | 611 | 0.010 |
Why?
|
Dactinomycin | 1 | 1992 | 304 | 0.010 |
Why?
|
Endothelium | 2 | 1985 | 763 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1996 | 1900 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13506 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1992 | 452 | 0.010 |
Why?
|
Visual Acuity | 1 | 2001 | 2677 | 0.010 |
Why?
|
DNA Primers | 1 | 1996 | 2815 | 0.010 |
Why?
|
Cholesterol | 1 | 2000 | 2902 | 0.010 |
Why?
|
Massachusetts | 1 | 2004 | 8836 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1997 | 3090 | 0.010 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 1992 | 299 | 0.010 |
Why?
|
Factor VIII | 2 | 1983 | 349 | 0.010 |
Why?
|
Length of Stay | 1 | 2004 | 6420 | 0.010 |
Why?
|
Sodium | 1 | 1995 | 1589 | 0.010 |
Why?
|
Kidney Cortex | 1 | 1990 | 168 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1994 | 2468 | 0.010 |
Why?
|
Platelet Aggregation | 2 | 1983 | 771 | 0.010 |
Why?
|
Software | 1 | 2003 | 4433 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2006 | 7400 | 0.010 |
Why?
|
Family | 1 | 2000 | 3193 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2006 | 20120 | 0.000 |
Why?
|
Diabetic Nephropathies | 1 | 1995 | 972 | 0.000 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1994 | 2508 | 0.000 |
Why?
|
Thiophenes | 1 | 1992 | 569 | 0.000 |
Why?
|
Antigens | 2 | 1983 | 1441 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 2000 | 11066 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6067 | 0.000 |
Why?
|
Aldosterone | 2 | 1981 | 869 | 0.000 |
Why?
|
Algorithms | 1 | 2006 | 14023 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 2007 | 9025 | 0.000 |
Why?
|
Hepatic Veins | 1 | 1986 | 112 | 0.000 |
Why?
|
Physicians | 1 | 2003 | 4583 | 0.000 |
Why?
|
Genes | 1 | 1989 | 1820 | 0.000 |
Why?
|
Psychotic Disorders | 1 | 2000 | 3219 | 0.000 |
Why?
|
Mannitol | 1 | 1985 | 177 | 0.000 |
Why?
|
Base Sequence | 1 | 1996 | 12404 | 0.000 |
Why?
|
beta-Thromboglobulin | 1 | 1983 | 20 | 0.000 |
Why?
|
Indium | 1 | 1983 | 47 | 0.000 |
Why?
|
Guanfacine | 1 | 1983 | 51 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 17598 | 0.000 |
Why?
|
Receptors, Opioid | 1 | 1983 | 145 | 0.000 |
Why?
|
Adrenergic alpha-Agonists | 1 | 1983 | 177 | 0.000 |
Why?
|
Radioisotopes | 1 | 1983 | 501 | 0.000 |
Why?
|
Platelet Function Tests | 1 | 1983 | 271 | 0.000 |
Why?
|
California | 1 | 1985 | 1431 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1981 | 397 | 0.000 |
Why?
|
Methylation | 1 | 1984 | 1070 | 0.000 |
Why?
|
Cell Count | 1 | 1985 | 1831 | 0.000 |
Why?
|
Osmolar Concentration | 1 | 1981 | 658 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 36418 | 0.000 |
Why?
|
Seasons | 1 | 1985 | 1517 | 0.000 |
Why?
|
Prospective Studies | 1 | 2004 | 54419 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2000 | 17889 | 0.000 |
Why?
|
Aorta | 1 | 1986 | 2040 | 0.000 |
Why?
|
Myocardium | 1 | 1990 | 4746 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1981 | 2478 | 0.000 |
Why?
|
Blood Proteins | 1 | 1981 | 1172 | 0.000 |
Why?
|
Signal Transduction | 1 | 1995 | 23415 | 0.000 |
Why?
|
Sex Factors | 1 | 1985 | 10552 | 0.000 |
Why?
|
Child | 2 | 1985 | 80134 | 0.000 |
Why?
|
Child, Preschool | 1 | 1985 | 42217 | 0.000 |
Why?
|